Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); Hub Group, Inc. (NASDAQ: HUBG); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your Behalf

Grabar Law Office is soliciting Aardvark Therapeutics investors who purchased shares around the company's February 2025 IPO to lead a class action. The investigation follows a securities class action alleging that the company made materially false statements regarding the safety profile of its lead drug candidate, ARD-101.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.